RESMED
Clinical Trials
101
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (75 trials with phase data)• Click on a phase to view related trials
ASV Therapy for Insomnia
- Conditions
- InsomniaInsomnia (Moderate)
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- ResMed
- Target Recruit Count
- 25
- Registration Number
- NCT07011966
- Locations
- 🇺🇸
C.S. Mott Center, Detroit, Michigan, United States
Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
- Conditions
- Obstructive Sleep Apnea (OSA)
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- ResMed
- Target Recruit Count
- 300
- Registration Number
- NCT06930404
Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- ResMed
- Target Recruit Count
- 80
- Registration Number
- NCT06769607
- Locations
- 🇦🇺
ResMed Ltd, Bella Vista, New South Wales, Australia
PAP Systems External Clinical Studies (ECS)
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- ResMed
- Target Recruit Count
- 30
- Registration Number
- NCT06562205
PAP Systems Internal Clinical Studies (ICS)
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- ResMed
- Target Recruit Count
- 30
- Registration Number
- NCT06173050
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
ResMed Launches NightOwl: FDA-Cleared Home Sleep Apnea Test Now Available Across US
ResMed's NightOwl, an FDA-cleared home sleep apnea test utilizing fingertip sensor technology, is now available nationwide to simplify obstructive sleep apnea diagnosis from patients' homes.
ResMed Expert Dr. Alison Wimms Joins Incannex's OSA Clinical Advisory Board for IHL-42X Development
Incannex Healthcare has appointed sleep medicine expert Dr. Alison Wimms to their newly formed IHL-42X Obstructive Sleep Apnea Clinical Advisory Board, strengthening their clinical development expertise.
ADVENT-HF Trial Shows Promise for Peak Flow-Triggered ASV in Heart Failure Patients with Sleep Apnea
The ADVENT-HF trial demonstrated that peak flow-triggered adaptive servo-ventilation (ASV) devices improved sleep quality and quality of life in heart failure patients.